Clinical Trial Update: Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing

View source ↗

Summary

This clinical trial update reports termination of a study on Cardiovasculorenal phenotyping in Fabry disease using noninvasive testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Fabry Disease | Status: TERMINATED